Interleukin 6 promotes endometrial cancer growth through an autocrine feedback loop involving ERK-NF-κB signaling pathway

Biochemical and Biophysical Research Communications

Volumn 446, Issue 1, 2014, Pages 167-172

  Che, Qi ^a   Liu, Bin Ya ^a   Wang, Fang Yuan ^a   He, Yin Yan ^a   Lu, Wen ^a   Liao, Yun ^a   Gu, Wei ^a   Wan, Xiao Ping ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

Autocrine; Endometrial carcinoma; IL 6; Proliferation

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CANCER GROWTH; CONTROLLED STUDY; DRUG MECHANISM; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AUTOCRINE; ENDOMETRIAL CARCINOMA; IL-6; PROLIFERATION;

ANIMALS; AUTOCRINE COMMUNICATION; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; ENDOMETRIAL NEOPLASMS; FEEDBACK, PHYSIOLOGICAL; FEMALE; HETEROGRAFTS; HUMANS; INTERLEUKIN-6; MAP KINASE SIGNALING SYSTEM; MICE; MICE, NUDE; NF-KAPPA B; RNA, MESSENGER; RNA, NEOPLASM; SIGNAL TRANSDUCTION;

EID: 84898005710     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.02.080     Document Type: Article

References (17)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics CA Cancer J. Clin. 62 2012 2012 10 29
2. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
3. F. Modugno, R.B. Ness, C. Chen, and N.S. Weiss Inflammation and endometrial cancer: a hypothesis Cancer Epidemiol. Biomarkers Prev. 14 2005 2840 2847
4. A. Mantovani, B. Savino, M. Locati, L. Zammataro, P. Allavena, and R. Bonecchi The chemokine system in cancer biology and therapy Cytokine Growth Factor Rev. 21 2010 27 39
5. D. Drygin, C.B. Ho, M. Omori, J. Bliesath, C. Proffitt, R. Rice, A. Siddiqui-Jain, S. O'Brien, C. Padgett, J.K. Lim, K. Anderes, W.G. Rice, and D. Ryckman Protein kinase CK2 modulates IL-6 expression in inflammatory breast cancer Biochem. Biophys. Res. Commun. 415 2011 163 167
6. A. Sidhu, P.J. Miller, and A.D. Hollenbach FOXO1 stimulates ceruloplasmin promoter activity in human hepatoma cells treated with IL-6 Biochem. Biophys. Res. Commun. 404 2011 963 967
7. Q. Che, B.Y. Liu, Y. Liao, H.J. Zhang, T.T. Yang, Y.Y. He, Y.H. Xia, W. Lu, X.Y. He, Z. Chen, F.Y. Wang, X.P. Wan, Activation of a positive feedback loop involving IL-6 and aromatase promotes intratumoral 17beta-estradiol biosynthesis in endometrial carcinoma microenvironment, Int. J. Cancer (2013), http://dx.doi.org/10.1002/ijc.28679. [Epub ahead of print].
8. H.O. Smith, N.D. Stephens, C.R. Qualls, T. Fligelman, T. Wang, C.Y. Lin, E. Burton, J.K. Griffith, and J.W. Pollard The clinical significance of inflammatory cytokines in primary cell culture in endometrial carcinoma Mol. Oncol. 7 2013 41 54
9. P. Sansone, G. Storci, S. Tavolari, T. Guarnieri, C. Giovannini, M. Taffurelli, C. Ceccarelli, D. Santini, P. Paterini, K.B. Marcu, P. Chieco, and M. Bonafe IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland J. Clin. Invest. 117 2007 3988 4002
10. H. Korkaya, G.I. Kim, A. Davis, F. Malik, N.L. Henry, S. Ithimakin, A.A. Quraishi, N. Tawakkol, R. D'Angelo, A.K. Paulson, S. Chung, T. Luther, H.J. Paholak, S. Liu, K.A. Hassan, Q. Zen, S.G. Clouthier, and M.S. Wicha Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population Mol. Cell 47 2012 570 584
11. D. Iliopoulos, H.A. Hirsch, and K. Struhl An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation Cell 139 2009 693 706
12. L. Dossus, A. Lukanova, S. Rinaldi, N. Allen, A.E. Cust, S. Becker, A. Tjonneland, L. Hansen, K. Overvad, N. Chabbert-Buffet, S. Mesrine, F. Clavel-Chapelon, B. Teucher, J. Chang-Claude, H. Boeing, D. Drogan, A. Trichopoulou, V. Benetou, C. Bamia, D. Palli, C. Agnoli, R. Galasso, R. Tumino, C. Sacerdote, H.B. Bueno-de-Mesquita, F.J. van Duijnhoven, P.H. Peeters, N.C. Onland-Moret, M.L. Redondo, N. Travier, M.J. Sanchez, J.M. Altzibar, M.D. Chirlaque, A. Barricarte, E. Lundin, K.T. Khaw, N. Wareham, V. Fedirko, I. Romieu, D. Romaguera, T. Norat, E. Riboli, and R. Kaaks Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort - a factor analysis Am. J. Epidemiol. 177 2013 787 799
13. S. Bellone, K. Watts, S. Cane, M. Palmieri, M.J. Cannon, A. Burnett, J.J. Roman, S. Pecorelli, and A.D. Santin High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer Gynecol. Oncol. 98 2005 92 98
14. J. Scheller, N. Ohnesorge, and S. Rose-John Interleukin-6 trans-signalling in chronic inflammation and cancer Scand. J. Immunol. 63 2006 321 329
15. S.P. Gao, K.G. Mark, K. Leslie, W. Pao, N. Motoi, W.L. Gerald, W.D. Travis, W. Bornmann, D. Veach, B. Clarkson, and J.F. Bromberg Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas J. Clin. Invest. 117 2007 3846 3856
16. Z.C. Hartman, X.Y. Yang, O. Glass, G. Lei, T. Osada, S.S. Dave, M.A. Morse, T.M. Clay, and H.K. Lyerly HER2 overexpression elicits a proinflammatory IL-6 autocrine signaling loop that is critical for tumorigenesis Cancer Res. 71 2011 4380 4391
17. C. Zhang, X. Kong, C. Liu, Z. Liang, H. Zhao, W. Tong, G. Ning, W. Shen, L. Yao, and S. Feng ERK2 small interfering RNAs prevent epidural fibrosis via the efficient inhibition of collagen expression and inflammation in laminectomy rats Biochem. Biophys. Res. Commun. 444 2014 395 400